The newly diversified experimental strategies to treat cancer include those that involve tweaks to host immunity. A recently described strategy, conducted in mouse models of cancer, targets tumor cells while simultaneously boosting T-cell function.
No takes yet. Share an insight, caveat, or question.
Ralph J. DeBerardinis (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: